196 related articles for article (PubMed ID: 2550625)
1. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
[TBL] [Abstract][Full Text] [Related]
2. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
Salas SP; Roblero JS; López LF; Tachibana S; Huidobro-Toro JP
J Pharmacol Exp Ther; 1992 Sep; 262(3):979-86. PubMed ID: 1356155
[TBL] [Abstract][Full Text] [Related]
3. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
Huidobro-Toro JP; Parada S
Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
[TBL] [Abstract][Full Text] [Related]
4. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
6. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
Leander JD; Hart JC; Zerbe RL
J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
[TBL] [Abstract][Full Text] [Related]
7. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
Richards ML; Sadée W
J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
[TBL] [Abstract][Full Text] [Related]
8. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
[TBL] [Abstract][Full Text] [Related]
9. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
[TBL] [Abstract][Full Text] [Related]
10. Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine.
Leander JD; Zerbe RL; Hart JC
J Pharmacol Exp Ther; 1985 Aug; 234(2):463-9. PubMed ID: 2991502
[TBL] [Abstract][Full Text] [Related]
11. Effects of central administration of morphine on renal function in conscious rats.
Danesh S; Walker LA
J Pharmacol Exp Ther; 1988 Feb; 244(2):640-5. PubMed ID: 3346840
[TBL] [Abstract][Full Text] [Related]
12. The influence of the kappa-agonist bremazocine on ingestive behaviour in mice and rats.
Hartig U; Opitz K
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):4-12. PubMed ID: 6307194
[TBL] [Abstract][Full Text] [Related]
13. Negative modulation of nitric oxide production by neurotensin as a putative mechanism of the diuretic action of SR 48692 in rats.
Croci T; Landi M; Gully D; Maffrand JP; Le Fur G; Manara L
Br J Pharmacol; 1997 Apr; 120(7):1312-8. PubMed ID: 9105707
[TBL] [Abstract][Full Text] [Related]
14. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
Leander JD
Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
[TBL] [Abstract][Full Text] [Related]
15. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
Shearman GT; Stenfors C
Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for benzomorphan-selective receptors in rats.
Gmerek DE; Cowan A
J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
Fuller RW; Leander JD
J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
[TBL] [Abstract][Full Text] [Related]
18. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
19. Azidomorphines and heterogenous opiate receptors.
Fürst S; Wagner TA; Knoll J
Pol J Pharmacol Pharm; 1988; 40(6):627-34. PubMed ID: 2855884
[TBL] [Abstract][Full Text] [Related]
20. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
